首页> 美国卫生研究院文献>Biomaterials Research >Evaluation of ciprofloxacin and metronidazole encapsulated biomimetic nanomatrix gel on Enterococcus faecalis and Treponema denticola
【2h】

Evaluation of ciprofloxacin and metronidazole encapsulated biomimetic nanomatrix gel on Enterococcus faecalis and Treponema denticola

机译:环丙沙星和甲硝唑封装的仿生纳米基质凝胶对粪肠球菌和密螺旋体的评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundA triple antibiotic mixture (ciprofloxacin; CF, metronidazole; MN, and minocycline; MC) has been used for dental root canal medicaments in pulp regeneration therapy. However, tooth discolorations, cervical root fractures, and inadequate pulp-dentin formation have been reported due to the triple antibiotic regimen. Therefore, an antibiotic encapsulated biomimetic nanomatrix gel was developed to minimize the clinical limitations and maximize a natural healing process in root canal infections. In this study, minimal bacterial concentrations (MBC) of the selected antibiotics (CF and MN) were tested in 14 representative endodontic bacterial species. Then MBC of each CF and MN were separately encapsulated within the injectable self-assembled biomimetic nanomatrix gel to evaluate antibacterial level on Enterococcus faecalis and Treponema denticola.
机译:背景技术三种抗生素混合物(环丙沙星; CF,甲硝唑; MN和米诺环素; MC)已用于牙髓再生治疗中的牙根管药物。但是,由于采用了三重抗生素治疗方案,已报道了牙齿变色,宫颈根部骨折和牙髓-牙本质形成不足。因此,开发了一种抗生素包封的仿生纳米基质凝胶,以最小化临床局限性并最大化根管感染的自然愈合过程。在这项研究中,在14种代表性牙髓细菌种类中测试了所选抗生素(CF和MN)的最低细菌浓度(MBC)。然后将每个CF和MN的MBC分别封装在可注射的自组装仿生纳米基质凝胶中,以评估粪肠球菌和密螺旋体的抗菌水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号